Literature DB >> 22898545

Neural and behavioral responses to low-grade inflammation.

Andrew J Tarr1, Qun Chen, Yufen Wang, John F Sheridan, Ning Quan.   

Abstract

Neural and behavioral responses after peripheral immune challenge have been observed in numerous studies. The majority of these studies have utilized relatively high doses of lipopolysaccharide (LPS) as the immune stimulant. Little attention has been given to the effects of LPS dose ranges that simulate low grade-inflammation. The current studies were designed to characterize neural and behavioral responses following low-dose LPS stimulation. Results show burrowing and open field activity was significantly impaired following a single i.p. injection of 10, but not 1, μg/kg of LPS. In addition, following repeated 1 μg/kg LPS administration for 10 days, animals showed the progressive development of motor deficits over time. To correlate behavior with CNS activity, cFos activation was determined in the paraventricular nucleus, nucleus of the solitary tract, central amygdaloid nucleus, and ventrolateral medulla. Data revealed there was a dose-dependent activation in all brain areas examined, but only the PVN showed significant activation by low-dose LPS. Additionally, animals that received 1 μg/kg of LPS for 8 days had PVN cFos activation similar to animals that received a single 10 μg/kg LPS injection. These data demonstrate neural and behavior responses can be induced by low-grade inflammation and chronic exposure to sub-threshold levels of LPS can precipitate significantly heightened neural and behavioral responses.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898545      PMCID: PMC3478741          DOI: 10.1016/j.bbr.2012.07.038

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  35 in total

Review 1.  Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease.

Authors:  Zafar A Usmani; Kristin V Carson; Jien N Cheng; Adrian J Esterman; Brian J Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  The role of immune dysfunction in the pathophysiology of autism.

Authors:  Charity Onore; Milo Careaga; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2011-08-28       Impact factor: 7.217

3.  Lipopolysaccharide-induced sickness behaviour evaluated in different models of anxiety and innate fear in rats.

Authors:  Gabriel S Bassi; Alexandre Kanashiro; Francele M Santin; Glória E P de Souza; Manoel J Nobre; Norberto C Coimbra
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-12-02       Impact factor: 4.080

4.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis.

Authors:  Michelle A Erickson; William A Banks
Journal:  Brain Behav Immun       Date:  2011-06-17       Impact factor: 7.217

5.  Location-specific activation of the paraventricular nucleus of the hypothalamus by localized inflammation.

Authors:  Natalya Belevych; Krystal Buchanan; Qun Chen; Michael Bailey; Ning Quan
Journal:  Brain Behav Immun       Date:  2010-05-31       Impact factor: 7.217

Review 6.  The role of inflammation in the pathophysiology of depression: different treatments and their effects.

Authors:  Francis E Lotrich; Hani El-Gabalawy; Lyn C Guenther; Carl F Ware
Journal:  J Rheumatol Suppl       Date:  2011-11

7.  Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.

Authors:  Michael Maes; Frank N M Twisk; Marta Kubera; Karl Ringel
Journal:  J Affect Disord       Date:  2011-10-04       Impact factor: 4.839

8.  Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients.

Authors:  Andreas Hillenbrand; Uwe Knippschild; Manfred Weiss; Hubert Schrezenmeier; Doris Henne-Bruns; Markus Huber-Lang; Anna M Wolf
Journal:  BMC Surg       Date:  2010-09-09       Impact factor: 2.102

9.  Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide.

Authors:  J P Konsman; J Veeneman; C Combe; S Poole; G N Luheshi; R Dantzer
Journal:  Eur J Neurosci       Date:  2008-12       Impact factor: 3.386

Review 10.  Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

Authors:  Andrew H Miller; Vladimir Maletic; Charles L Raison
Journal:  Biol Psychiatry       Date:  2009-01-15       Impact factor: 13.382

View more
  17 in total

1.  Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Authors:  M K Larsson; A Faka; M Bhat; S Imbeault; M Goiny; F Orhan; A Oliveros; S Ståhl; X C Liu; D S Choi; K Sandberg; G Engberg; L Schwieler; S Erhardt
Journal:  Neurochem Res       Date:  2016-05-10       Impact factor: 3.996

Review 2.  In-depth conversation: spectrum and kinetics of neuroimmune afferent pathways.

Authors:  Ning Quan
Journal:  Brain Behav Immun       Date:  2014-02-22       Impact factor: 7.217

3.  Kinetic characteristics of euflammation: the induction of controlled inflammation without overt sickness behavior.

Authors:  Andrew J Tarr; Xiaoyu Liu; Nathaniel S Reed; Ning Quan
Journal:  Brain Behav Immun       Date:  2014-06-12       Impact factor: 7.217

4.  Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model.

Authors:  P N De Francesco; S Valdivia; A Cabral; M Reynaldo; J Raingo; I Sakata; S Osborne-Lawrence; J M Zigman; M Perelló
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

5.  Immunomodulatory T cell death associated gene-8 (TDAG8) receptor in depression-associated behaviors.

Authors:  Katherine M J McMurray; Lauren Larke Vollmer; Rebecca Ahlbrand; Joshua Thomas; Andrew Winter; Ian P Lewkowich; Renu Sah
Journal:  Physiol Behav       Date:  2019-07-02

6.  Reducing inflammation and rescuing FTD-related behavioral deficits in progranulin-deficient mice with α7 nicotinic acetylcholine receptor agonists.

Authors:  S Sakura Minami; Vivian Shen; David Le; Grietje Krabbe; Rustam Asgarov; Liberty Perez-Celajes; Chih-Hung Lee; Jinhe Li; Diana Donnelly-Roberts; Li Gan
Journal:  Biochem Pharmacol       Date:  2015-07-20       Impact factor: 5.858

7.  A potential role for the acid-sensing T cell death associated gene-8 (TDAG8) receptor in depression-like behavior.

Authors:  Lauren Larke Vollmer; Sarah N Schmeltzer; Rebecca Ahlbrand; Renu Sah
Journal:  Physiol Behav       Date:  2015-03-11

8.  Diet-induced obesity attenuates cytokine production following an immune challenge.

Authors:  Katherine M Baumgarner; Sharay Setti; Carolyn Diaz; Alyssa Littlefield; Amanda Jones; Rachel A Kohman
Journal:  Behav Brain Res       Date:  2014-03-20       Impact factor: 3.332

9.  Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.

Authors:  Arturo Silvero-Isidre; Sergio Morínigo-Guayuán; Aaron Meza-Ojeda; Marcelo Mongelós-Cardozo; Claudia Centurión-Wenninger; Susy Figueredo-Thiel; Diego F Sanchez; Nidia Acosta
Journal:  Parasitol Res       Date:  2017-12-01       Impact factor: 2.289

Review 10.  Neuropeptides and the microbiota-gut-brain axis.

Authors:  Peter Holzer; Aitak Farzi
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.